VLA 0.00% $1.75 viralytics limited

more good news in the bio space:From SMH:In merger and...

  1. 89 Posts.
    more good news in the bio space:

    From SMH:

    In merger and acquisition news, Israel's Teva Pharmaceutical Industries, the world's largest generic drug maker, announced the takeover of biopharma firm Cephalon in a $6.8 billion deal, weeks after Cephalon rejected a hostile $5.7 billion bid from Canadian firm Valeant.

    Teva offered $81.50 in cash for all of Cephalon's shares outstanding, representing a 39 percent premium on Cephalon's share value at the end of March, before Valeant launched its takeover bid.

    Teva shares were up 2.4 percent to $46.85, while Cephalon's surged 5.1 percent to $80.96.


 
watchlist Created with Sketch. Add VLA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.